Harvard Sylvan, OD: As our population ages there is a greater need for presbyopia-correcting contact lenses, but is there a corresponding demand? The Baby Boomers are now between 46 years old and 64 ...
Innovega, the company that brings the digital world closer to your eyes, has been tapped by The Pentagon to deliver a fully functioning prototype of contact lenses that uses their iOptiks system. The ...
Please provide your email address to receive an email when new articles are posted on . SALT LAKE CITY — CooperVision Inc. announced the U.S. launch of Biofinity Multifocal here at Optometry's Meeting ...
WASHINGTON, DC — Some of the newest multifocal contact lenses have elicited sky-high satisfaction rates in patient surveys, with almost all patients preferring them over their habitual lenses, ...
According to a clinical study funded by the National Institutes of Health (NIH), multifocal contact lenses were able to slow down and control the worsening of nearsightedness in children. Multifocal ...
The brand also expands daily disposable options for astigmatic adults with the launch of ACUVUE® OASYS MAX 1-Day for ASTIGMATISM, bringing pioneering innovation that delivers visual clarity and ...
ATLANTA--(BUSINESS WIRE)--US-based medical device company and inventor of the NaturalVue® (etafilcon A) Multifocal 1 Day Contact Lenses, Visioneering Technologies, Inc (ASX: VTI) (‘VTI’ or ‘The ...
The healthcare company introduced what it describes as the market's only daily disposable lens addressing both astigmatism and presbyopia simultaneously.
New Multifocal Daily Disposable Lens Provides Clear Vision at All Distances, All-Day Comfort and Helps Minimize Contact Lens Dryness Bausch + Lomb INFUSE Multifocal contact lenses are made with a next ...
JACKSONVILLE, Fla., March 15, 2021 /PRNewswire/ -- Johnson & Johnson Vision *, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies **, today introduced a new eye ...
Children wearing multifocal contact lenses had slower progression of their myopia, according to results from a clinical trial funded by the National Eye Institute, part of the National Institutes of ...